BLBD vs EW · P/E 14, rev $1.48B vs P/E 47, rev $1.39B
Blue Bird Corp (BLBD) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Blue Bird Corp (BLBD) is a farm & heavy construction machinery company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported BLBD revenue for 2025-09-27 was $1.48B. Net income was $127.7M. Revenue was up 9.9% from 2024-09-28 to 2025-09-27. BLBD currently screens at market cap $1.43B and trailing P/E 14.0.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
BLBD currently screens at market cap $1.43B and trailing P/E 14.0. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the BLBD and EW stock pages for the full models.
Not investment advice.